Page last updated: 2024-12-06
copper(ii) perchlorate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
copper(II) perchlorate: RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 28211 |
MeSH ID | M0172437 |
Synonyms (21)
Synonym |
---|
cupric perchlorate 6h2o |
13770-18-8 |
cu(ii) perchlorate |
copper perchloric acid |
cupric perchlorate |
copper diperchlorate |
perchloric acid, copper(2+) salt (2:1) |
ibe83vve7t , |
copper(ii) perchlorate |
perchloric acid, copper(2+) salt |
einecs 237-391-4 |
unii-ibe83vve7t |
AKOS015916154 |
copper perchlorate (cu(clo4)2) |
copper bis(perchlorate) |
cupric perchlorate [mi] |
perchloric acid copper(2+) salt (2:1) |
copper perchlorate |
copper;diperchlorate |
Q15628157 |
DTXSID40890720 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 47.83
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (47.83) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |